home.social

#peterwilden — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #peterwilden, aggregated by home.social.

  1. Switzerland @[email protected] ·

    europesays.com/ch/106156/ Samsung Biologics Acquires Swiss PolyPeptide Group for approximately $1.8 Billion, Targeting Obesity Drug Market — BigGo Finance #CDMO #DraupnirHolding #EliLilly #Ferring #GLP1 #JohnRim #PeterWilden #PolyPeptideGroup #SamsungBiologics #SIXSwissExchange #Swiss #Switzerland

    #switzerland #swiss #sixswissexchange #samsungbiologics #polypeptidegroup #peterwilden
  2. Switzerland @[email protected] ·

    Switzerland: Samsung Biologics to acquire PolyPeptide for US$1.8bn

    Listed South Korean CDMO, Samsung Biologics, is acquiring all shares in SIX-listed PolyPeptide, a specialised CDMO for peptide-based…
    #Switzerland #CH #Europe #Europa #EU #Homburger #JohnRim #MorganStanley #Nachrichten #Nouvelles #PeterWilden #PolyPeptideGroup #SamsungBiologics #schweiz #Suisse #switzerland
    europesays.com/3142877/

    #suisse #schweiz #samsungbiologics #polypeptidegroup #peterwilden #nouvelles
  3. Korea @[email protected] ·

    Switzerland: Samsung Biologics to acquire PolyPeptide for US$1.8bn

    Listed South Korean CDMO, Samsung Biologics, is acquiring all shares in SIX-listed PolyPeptide, a specialised CDMO for peptide-based…
    #EuropeSays #Korea #KR #SamsungBiologics #Homburger #JohnRim #MorganStanley #PeterWilden #PolyPeptideGroup #Samsung #Switzerland
    europesays.com/korea/92404/

    #switzerland #samsung #polypeptidegroup #peterwilden #morganstanley #johnrim
  4. Switzerland @[email protected] ·

    europesays.com/ch/105623/ Switzerland: Samsung Biologics to acquire PolyPeptide for US$1.8bn #Homburger #JohnRim #MorganStanley #PeterWilden #PolyPeptideGroup #SamsungBiologics #Switzerland

    #switzerland #samsungbiologics #polypeptidegroup #peterwilden #morganstanley #johnrim
  5. Korea @[email protected] ·

    Samsung Biologics to Acquire Swiss Peptide CDMO for approximately $1.8 Billion, Targeting Obesity Drug Market — BigGo Finance

    Samsung Biologics (207940.KS) announced on the 20th that it will acquire PolyPeptide Group, a global peptide contract development…
    #EuropeSays #Korea #KR #Samsung #207940.KS #GLP-1 #JohnRim #obesitytreatment #PeptideCDMO #PeterWilden #PolyPeptideGroup #SamsungBiologics #SamsungGroup #Switzerland
    europesays.com/korea/91608/

    #switzerland #samsunggroup #samsungbiologics #polypeptidegroup #peterwilden #peptidecdmo
  6. Switzerland @[email protected] ·

    europesays.com/ch/105401/ Samsung Biologics to Acquire Swiss Peptide CDMO for approximately $1.8 Billion, Targeting Obesity Drug Market — BigGo Finance #207940KS #GLP1 #JohnRim #ObesityTreatment #PeptideCDMO #PeterWilden #PolyPeptideGroup #SamsungBiologics #Swiss #Switzerland

    #switzerland #swiss #samsungbiologics #polypeptidegroup #peterwilden #peptidecdmo